Product Images Aripiprazole
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 21 images provide visual information about the product associated with Aripiprazole NDC 50228-328 by Sciegen Pharmaceuticals Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This document appears to be a chart or table showing the effect of various drugs on the absorption or metabolism of the medication aripiprazole. It lists specific drugs and their impact, including whether they inhibit or induce certain enzymes that affect how aripiprazole is processed in the body. There are also percentage values indicating the degree of change in aripiprazole absorption or metabolism when these drugs are taken together.*
This text provides information about the effect of different drugs, including CYP3A4 inhibitor ketoconazole, CYP2D6 inhibitor quinidine, CYP3A4 inducer carbamazepine, and gastric acid blockers like famotidine or other drugs like valproate, lithium, and lorazepam, on Aripiprazole. However, it is not clear what changes these drugs cause or how they affect Aripiprazole.*
This is a graph showing the percentage of subjects who experienced a relapse while taking either aripiprazole or placebo over time, measured in days from randomization. The x-axis shows the number of days and the y-axis shows the proportion with relapse. The data is presented in two columns, one for aripiprazole and one for placebo. The graph also displays the number of subjects at risk for each time point. There are no other indications of what the study is about or what condition the medication is used for.*
This is a bottle of Aripiprazole tablets, USP with each tablet containing 2 mg of the drug. It is important to follow the usual dosage, as indicated in the prescribing information that comes with it. It should be stored in a tightly closed container at a temperature of 25°C (77°F) but excursions between 15°C to 30°C (59°F to 86°F) are also allowed. The medication guide must be provided to each patient by the pharmacist. The bottle contains 1000 tablets and its distribution is restricted to those with a prescription. The drug is manufactured by Scieen Pharmaceuticals Inc. in Hauppauge, NY 11788.*
This is a description of Aripiprazole Tablets, USP that contains 20mg of aripiprazole in each tablet. The usual dose should be obtained from the accompanying prescription information. It should be stored in a tightly closed container at a temperature between 15°C to 30°C. The medication should be kept out of reach of children. Each patient should be given a medication guide. It's a prescription medication manufactured by ScieGen Pharmaceuticals, Inc. The product details include NDC 50228-328-30, Rev 05/16, and Lot and Exp numbers are not available in the text.*
This is a description of Aripiprazole Tablets, USP containing 30 mg of aripiprazole per tablet. The usual dosage and prescribing information must be followed, and the tablets should be stored in closed containers between 15°C to 30°C. The medication should be kept out of reach of children. The lot number is BXP: 3, and the tablets are manufactured by ScieGen Pharmaceuticals, Inc in Hauppauge, NY.*
This is a medication called Aripiprazole Tablets, USP. Each tablet contains 30 mg of aripiprazole, USP. The usual dosage information can be found in the accompanying prescribing information. It should be stored in a tightly closed container at a temperature between 15°C to 30°C (59°F to 86°F). This medication should be kept out of the reach of children. A Medication Guide should be provided to each patient by the pharmacist. The drug has been manufactured by ScieGen Pharmaceuticals, Inc. in Hauppauge, NY 11788.*
This is a medication description for Aripiprazole tablets, USP, which contains 2 mg of arpiprazole. The usual dosage and prescribing information can be found with the medication. It should be stored at a temperature between 15°C to 30°C (59°F to 86°F). The medication should be kept out of the reach of children. This medicine is manufactured by ScieGen Pharmaceuticals Inc. in Hauppauge, NY. The Lot and expiration date numbers are not available.*
This is a description of medication, specifically Aripiprazole Tablets, USP containing 5 mg of aripiprazole. The usual dosage information is not provided and it is recommended to read the accompanying prescribing information. The medication should be stored in tightly closed containers between 15°C to 30°C (59°F to 86°F). It is important to keep this and all medications out of the reach of children. The medication guide should be dispensed separately to each patient by the pharmacist. The manufacturer is ScieGen Pharmaceutical, Inc. located in Hauppauge, NY 11788. NDC number is 50228-325-10.*
This is a description for Aripiprazole Tablets, USP containing 5mg arpiprazole. Users need to read the prescribing information before using it. It should be stored in a tightly closed container between 15°C to 30°C. The medication should be kept out of children's reach. The pharmacist is supposed to give each patient a medication guide. Available in a pack of 30 Tablets. It is manufactured by ScieGen Pharmaceuticals, Inc. in Hauppauge, NY 11788.*
Each tablet of Aripiprazole USP contains 10 mg. It is recommended to read the prescribing information for the usual dosage. The tablets should be stored in a tightly closed container at a temperature ranging between 15°C to 30°C (59°F to 86°F). The medication should be kept away from the reach of children. The medication guide should be provided separately to each patient. The details of the manufacturer of the medication are provided.*
Each tablet contains 10 mg of Aripiprazole, USP. It is a prescription medication that should be kept out of the reach of children. The usual dosage can be found in the accompanying prescribing information. Store the medicine at a temperature between 15°C to 30°C (59°F to 86°F). This medication guide should be dispensed to each patient. The tablets have been manufactured by ScieGen Pharmaceuticals, Inc. The Lot number and expiration date are not available.*
This is a medication called Aripiprazole, USP that is in tablet form. Each tablet contains 15g of the medication. The recommended dose is not provided in this text and patients should read the prescribing information. The medication should be stored in tightly closed containers at a temperature range of 15°C to 30°C. The medication should be kept away from children. A medication guide should be given to each patient along with the medication. The manufacturer of the medication is ScieGen Pharmaceutical, Inc. The other information such as NDC number, revision date, and brand name are also available.*
Each tablet contains 15 mg of aripiprazole, USP. The usual dosage and prescribing information should be consulted before use. The tablets should be stored in tightly closed containers at temperatures between 15°C to 30°C (59°F to 86°F). It is important to keep the medication out of reach of children. The medication guide should be dispensed to each patient by the pharmacist. The tablets are manufactured by ScieGen Pharmaceuticals, Inc. The lot number, expiration date, and NDC number are also provided.*
Each tablet of Aripiprazole contains 20mg of USP. For dosage instructions, refer to accompanying prescription information. Store in closed containers at T7°F (25°C) with temperature excursions allowed between 15°C to 30°C (59°F to 86°F). Keep all medication out of reach from children. This product has 1000 tablets and is only available on prescription. A separate medication guide is provided to each patient. This product is manufactured by ScieGen Pharmaceuticals Inc, Hauppauge NY.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.